Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy

Por Mohsen Keshavarz, Farid Solaymani-Mohammadi, Seyed Mohammad Miri, Amir Ghaemi
Publicado em 2019-06-01

Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice

Por Atefeh Saeedi, Malihe Naderi, Alijan Tabarraie, Mishar Kelishdi, Amir Ghaemi
Publicado em 2014-11-01

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

Por Seyed Mohammad Miri, Elham Tafsiri, William Chi Shing Cho, Amir Ghaemi
Publicado em 2020-10-01

Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran

Por Abdolvahab Moradi, Sareh Zhand, Amir Ghaemi, Naeme Javid, Masoud Bazouri, Alijan Tabarraei
Publicado em 2014-05-01

Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?

Por Mohsen Keshavarz, Ailar Sabbaghi, Seyed Mohammad Miri, Abolhasan Rezaeyan, Yaser Arjeini, Amir Ghaemi
Publicado em 2020-04-01

Efficacy of HPV-16 E7 Based Vaccine in a TC-1 Tumoric Animal Model of Cervical Cancer - page 483

Por Maryam Fazeli, Hoorieh Soleimanjahi, Amir Ghaemi, Mahdieh Farzanepour, Amir Amanzadeh, Seyed Reza Hashemi
Publicado em 2011-01-01

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Imm...

Por Seyed Mohammad Miri, Mir Saeed Ebrahimzadeh, Elahe Abdolalipour, Mahsa Yazdi, Hassan Hosseini Ravandi, Amir Ghaemi
Publicado em 2020-08-01